Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Clonazepam and Capsaicin for BMS
NCT05059418Unknown
- Sponsor
- Malmö University
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Transdermal Patches, Small Molecules
01
Overview
Randomised trial in burning mouth syndrome (BMS) comparing Clonazepam, Capsaicin and Placebo (3 arms). Primary endpoints: Pain intensity at 22 days and Patient satisfaction at 22 days. Status: unknown.
02
Drugs
clonazepamcapsaicin 8% patch
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT05059418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05059418.